14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £141.16 £183.01 Thursday, 8th Feb 2024 ERGO.L stock ended at £1,346.00. During the day the stock fluctuated 0% from a day low at £1,346.00 to a day high of £1,346.00.
90 days £141.16 £227.30
52 weeks £84.73 £227.30

Historical Entia Biosciences Inc prices

Date Open High Low Close Volume
Apr 06, 2023 £961.24 £1,020.00 £961.24 £977.00 148 339
Apr 05, 2023 £1,059.00 £1,059.00 £984.00 £991.00 287 476
Apr 04, 2023 £1,000.00 £1,055.00 £1,000.00 £1,054.00 64 756
Apr 03, 2023 £1,021.50 £1,066.00 £1,021.50 £1,036.00 62 407
Mar 31, 2023 £1,017.95 £1,034.00 £1,002.00 £1,022.00 89 223
Mar 30, 2023 £985.73 £1,024.00 £985.73 £1,024.00 329 380
Mar 29, 2023 £992.00 £992.00 £992.00 £992.00 0
Mar 28, 2023 £1,038.50 £1,038.50 £988.00 £992.00 248 290
Mar 27, 2023 £1,020.00 £1,034.00 £1,007.00 £1,028.00 468 733
Mar 24, 2023 £1,044.00 £1,044.00 £957.00 £1,004.00 126 350
Mar 23, 2023 £1,039.60 £1,039.60 £992.00 £1,004.00 34 031
Mar 22, 2023 £996.00 £1,048.00 £971.00 £1,004.00 676 223
Mar 21, 2023 £1,052.00 £1,070.00 £983.37 £997.00 343 904
Mar 20, 2023 £1,070.00 £1,070.00 £1,000.25 £1,020.00 42 093
Mar 17, 2023 £1,050.00 £1,056.00 £1,008.00 £1,036.00 78 601
Mar 16, 2023 £1,098.00 £1,098.00 £1,042.00 £1,046.00 41 524
Mar 15, 2023 £1,022.00 £1,116.60 £1,022.00 £1,040.00 48 205
Mar 14, 2023 £1,066.00 £1,066.00 £1,066.00 £1,066.00 0
Mar 13, 2023 £1,108.00 £1,138.00 £1,046.20 £1,066.00 84 628
Mar 10, 2023 £1,082.00 £1,138.00 £1,082.00 £1,122.00 55 336
Mar 09, 2023 £1,140.00 £1,190.00 £1,140.00 £1,142.00 41 140
Mar 08, 2023 £1,158.00 £1,158.00 £1,158.00 £1,158.00 0
Mar 07, 2023 £1,178.00 £1,184.00 £1,148.00 £1,158.00 129 067
Mar 06, 2023 £1,165.60 £1,172.00 £1,148.00 £1,172.00 38 811
Mar 03, 2023 £1,140.00 £1,166.00 £1,140.00 £1,156.00 77 357
Click to get the best stock tips daily for free!

About Entia Biosciences Inc

Entia Biosciences Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance service... ERGO.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT